Jamjoom Pharma and Bioventure Healthcare unite to enhance pharmaceutical access across the UAE, combining commercial expertise with quality pharmaceutical capabilities.
M42 unveils Ossi, a revolutionary multi-agent AI Clinical Platform designed to enhance clinician focus and patient care across leading healthcare facilities in the UAE and Bahrain
Abu Dhabi Biobank and AstraZeneca launch a transformative partnership to advance predictive healthcare, leveraging artificial intelligence and genomic data to improve disease detection and rare disease research.
The Emirates Drug Establishment strengthens regulatory partnerships with leading healthcare institutions during the Abu Dhabi Future Health Summit 2026.
M42's healthcare divisions partner with Re:Cognition Health to expand specialised memory and brain health services across the UAE, commencing at Mubadala Health Dubai.
Burjeel Holdings and Proximie establish transformative partnership to develop AI-powered surgical solutions, advancing operating room efficiency and clinical care across Abu Dhabi.
Abu Dhabi Stem Cells Centre and Miltenyi Biomedicine announce strategic collaboration to advance CAR-T therapy development and manufacturing in the UAE.
Future Health releases strategic framework outlining how Abu Dhabi's genomics, clinical research and specialist care capabilities can translate therapeutic innovation into patient treatments.
The UAE launches a pioneering five-year climate adaptation strategy to protect public health and ensure healthcare resilience amid evolving environmental challenges.
Burjeel Holdings and etisalat establish a strategic partnership to enhance healthcare accessibility, preventive health initiatives and employee well-being across the UAE.